Three more retractions for Vietnamese physicists who plagiarized a plagiarized paper

Last week, we brought you the story of Thong Duc Le and his colleagues, physicists who were forced to retract four papers, including one that cited, as we noted “their own study that had already been retracted for plagiarism.”

The team has now retracted three more papers: Continue reading Three more retractions for Vietnamese physicists who plagiarized a plagiarized paper

Authors retract two Cell Metabolism papers after “data were inappropriately removed from the laboratory”

A group of researchers at the University of Utah has retracted two papers from Cell Metabolism after they realized that a dismissed employee had tossed out data that were the basis of some error-laden figures.

Here’s the notice for both papers: Continue reading Authors retract two Cell Metabolism papers after “data were inappropriately removed from the laboratory”

Leading cancer vaccines researcher retracts paper for figure “discrepancies” flagged by watchdog blog

Gerold Schuler, a German immunology researcher who shared the 2006 Deutscher Krebspreis — aka the German Cancer Prize — for his work that contributed to cancer vaccines has retracted a paper in International Immunology following concerns raised by a German science watchdog blog.

Here’s the notice: Continue reading Leading cancer vaccines researcher retracts paper for figure “discrepancies” flagged by watchdog blog

Authors retract 2010 Archives of Otolaryngology-Head and Neck Surgery paper because of duplication

The authors of a 2010 paper in the Archives of Otolaryngology-Head and Neck Surgery have retracted it after realizing that their colleagues at other institutions had already published a paper based on the same findings.

Here’s the retraction notice: Continue reading Authors retract 2010 Archives of Otolaryngology-Head and Neck Surgery paper because of duplication

JACS makes it official, retracting Breslow “space dinosaurs” paper for “similarity to his previously published reviews”

Last month, we (and others) reported that the Journal of the American Chemical Society (JACS) had temporarily withdrawn a paper by a former president of the society after a number of chemists pointed out similarities between the March 25 article and previous ones by the author, Ronald Breslow.

The paper had drawn puzzled looks thanks to an April 11 press release — since deleted — headlined “Could ‘advanced’ dinosaurs rule other planets?” In its note last month, the journal said: Continue reading JACS makes it official, retracting Breslow “space dinosaurs” paper for “similarity to his previously published reviews”

Astrophysics retraction trail includes paper that plagiarized another already retracted for…plagiarism

Sometimes, the full story of scientific misdeeds isn’t clear until several retraction notices appear. Take the case of a group of Vietnamese astrophysicists led by Thong Duc Le.

If you were to read a Physics Letters B retraction notice about one of the group’s papers, “Search for cosmological time variation of the fine-structure constant using low-redshifts of quasar,” you wouldn’t have any idea why the paper was retracted, nor that the move was related to any other retractions: Continue reading Astrophysics retraction trail includes paper that plagiarized another already retracted for…plagiarism

Is misconduct more likely in drug trials than in other biomedical research?

A new paper by Chicago pharmacy researchers suggests that researchers performing drug studies are more likely to commit fraud than are their colleagues in the rest of biomedicine.

In the paper, “Retraction Publications in the Drug Literature,” which appears in Pharmacotherapy, Jennifer C. Samp, Glen T. Schumock, and A. Simon Pickard take a look at previous studies of retractions, including those by Grant Steen and John Budd, both of whose work we’ve covered. They also identify 742 retractions in the biomedical literature from 2000 to 2011, 102 of which were of drug studies, to analyze.

Noting the growing interest in retractions, they write that Continue reading Is misconduct more likely in drug trials than in other biomedical research?

Will a new literature format “radically alter” how scientists write, review, and read papers?

A group of authors at a Pittsburgh company have proposed a new way to write, review, and read scientific papers that they claim will “radically alter the creation and use of credible knowledge for the benefit of society.”

From the abstract of a paper appearing in the new Mary Liebert journal Disruptive Science and Technology, which, according to a press release, will “publish out-of-the-box concepts that will improve the way we live”: Continue reading Will a new literature format “radically alter” how scientists write, review, and read papers?

Retraction seven for Shouwei Han, this one in the American Journal of Physiology

ShouWei Han, who has been forced to retract six papers from various physiology journals following an investigation into his work by his former employer, the University of Louisville, has added another one to his tally.

Here’s the notice, from the American Journal of Physiology: Lung Cellular and Molecular Physiology: Continue reading Retraction seven for Shouwei Han, this one in the American Journal of Physiology

Weight loss surgeon who made up data loses job at University Hospital Leipzig

Edward Shang

Edward Shang, a weight loss surgeon who has now retracted two papers for fraudulent data, is out of his job at the University Hospital Leipzig.

According to a university release — which was apparently retracted for about an hour and which we’ve had trouble accessing at various points this morning — Shang’s employment contract with the Leipzig hospital is “terminated by mutual agreement with immediate effect.”

The release also says Continue reading Weight loss surgeon who made up data loses job at University Hospital Leipzig